Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines. - sprookjes - yvandenbroek - TriplyDB

Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines.

Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines.

http://www.wikidata.org/entity/Q46923743

about

Toxicity of amphetamines: an update Effect of MDMA-Induced Axotomy on the Dorsal Raphe Forebrain Tract in Rats: An In Vivo Manganese-Enhanced Magnetic Resonance Imaging Study New Insights on Different Response of MDMA-Elicited Serotonin Syndrome to Systemic and Intracranial Administrations in the Rat Brain Serotonin reuptake transporter deficiency modulates the acute thermoregulatory and locomotor activity response to 3,4-(±)-methylenedioxymethamphetamine, and attenuates depletions in serotonin levels in SERT-KO rats.The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine.Low striatal serotonin transporter protein in a human polydrug MDMA (ecstasy) user: a case study.Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopram.Vesicular monoamine transporter 2 and the acute and long-term response to 3,4-(±)-methylenedioxymethamphetamine.Monoamine reuptake inhibitors in Parkinson's disease.A developmental comparison of the neurobehavioral effects of ecstasy (MDMA)Effect of repeated exposure to MDMA on the function of the 5-HT transporter as assessed by synaptosomal 5-HT uptake.MDMA increases glutamate release and reduces parvalbumin-positive GABAergic cells in the dorsal hippocampus of the rat: role of cyclooxygenase Effects of a short-course MDMA binge on dopamine transporter binding and on levels of dopamine and its metabolites in adult male rats.MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen Pharmacology Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs.Effects of combined treatment with mephedrone and methamphetamine or 3,4-methylenedioxymethamphetamine on serotonin nerve endings of the hippocampus.MDMA pretreatment leads to mild chronic unpredictable stress-induced impairments in spatial learning.Evidence for a role of transporter-mediated currents in the depletion of brain serotonin induced by serotonin transporter substrates.Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation.The Nature of 3, 4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonergic Dysfunction: Evidence for and Against the Neurodegeneration Hypothesis.MDMA-induced neurotoxicity: long-term effects on 5-HT biosynthesis and the influence of ambient temperature.Serotonin excites hippocampal CA1 GABAergic interneurons at the stratum radiatum-stratum lacunosum moleculare border.Effects of stress and MDMA on hippocampal gene expression.The effect of amphetamine analogs on cleaved microtubule-associated protein-tau formation in the rat brain.3,4-Methylenedioxymethamphetamine induces differential regulation of tryptophan hydroxylase 2 protein and mRNA levels in the rat dorsal raphe nucleus.The role of adenosine A1 and A2A receptors in the caffeine effect on MDMA-induced DA and 5-HT release in the mouse striatum.3,4-methylenedioxymethamphetamine induces gene expression changes in rats related to serotonergic and dopaminergic systems, but not to neurotoxicity.MDMA induces Per1, Per2 and c-fos gene expression in rat suprachiasmatic nuclei.Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice.(±)-MDMA and its enantiomers: potential therapeutic advantages of R(-)-MDMA.3,4-Methylenedioxymethamphetamine causes cytotoxicity on 661W cells through inducing macrophage polarization.In vivo [¹⁸F] FDG PET imaging reveals that p-chloroamphetamine neurotoxicity is associated with long-term cortical and hippocampal hypometabolism.Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’): Neurodegeneration versus Neuromodulation.

P2860

Q22252794-DE3584FD-F1C1-4C6D-95AC-FD5396B12D28 Q28548147-CF714CEA-5E37-45F5-8737-31148645545C Q28552135-0376F0D9-0FDA-41A2-80EC-4589B20E0E15 Q33652473-0B27C18B-B6E6-4998-B02C-611A7B349D0F Q34025177-D1212EF7-BF1A-4C96-B097-55B36DF6F9BB Q34597927-CBF55980-5E57-49FD-9CFF-1EB8D7B3C85F Q34645756-A920F608-7E1D-4669-8CED-A33154746510 Q34760266-1A95C63E-9E3A-4B9F-BC43-3129DCA1F392 Q35165280-09F5EAC2-5941-4B4E-9C5C-E367F0FF6B00 Q35851128-60930973-BE83-46AA-921F-01EBB745C06D Q36625559-71D6D7B7-7652-447F-BFB1-1399F7633E31 Q36654252-0108CB92-B695-42C9-B058-C413DD345F37 Q36875417-315E7B2F-48B4-4DC9-8C08-4CF7CB3FD151 Q37149027-F5B13962-04E9-4C30-9249-89E24A8E33D4 Q37307331-D8379217-5D34-4B03-8CE2-24EFE558BDF8 Q37381303-D76B2FED-6F9D-40F4-8A0F-AE7E9714EE3D Q37452207-14001372-68F1-4D2E-9333-6B6E560B5557 Q37705731-04E9A9F5-B195-4129-B429-D9B6854952CD Q37789757-3FA0342C-2E3E-407A-9035-2DD0C8DE32FD Q37925507-C08C15F0-39E6-4EAB-8070-E30FE01C2620 Q38758177-855A5189-51BA-446B-9C74-ABDE1DDF4361 Q41245277-A410A174-9402-474C-A03B-72C6619BD8B4 Q41907090-0EDC94E5-BD1C-45C3-9C22-8E82F329F4FB Q42135246-3C5E456F-EAF3-4C1C-BE33-F9AA1908FC57 Q42348445-99C46973-9B6E-4B70-B9FB-078AC7BEFB8B Q43180903-66C1696A-633B-4095-A12C-3140942FCE3E Q43543985-BD242610-D7C2-42ED-BBDB-7B7CA903752E Q43729285-3F1EE88B-2469-442A-AE5D-1305F52E48DB Q47602688-CA29D27A-36A7-4C73-9C9C-31990A233698 Q47777762-386B7DB7-86C7-4FC1-A9D3-CDB1CA684335 Q48029190-D9BF7688-070F-4FC4-88BB-C7ED5A485DA6 Q48505973-9683B127-FA77-4002-9D83-4B03B7630E7E Q55043421-38B7EBCF-DAD4-4B32-A208-F66D9FB5434D

P2860

Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines.

http://www.wikidata.org/entity/Q46923743

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines.

@en

Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines.

@nl

type

label

Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines.

@en

Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines.

@nl

prefLabel

Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines.

@en

Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines.

@nl

P1433

Q46923743-8956F57B-E488-4152-B657-3B6F8B0F43CF

P1476

Q46923743-BAFCECBE-C98A-4995-9F8F-F9EED6960D7C

P2093

Q46923743-1EC9062F-91F9-4651-B52D-BDB25F84A411

Q46923743-2088F3FF-8625-47B3-B9A7-84361BA50182

Q46923743-280EE11D-2D37-4767-B8F2-981B5E84A1C9

Q46923743-38736B8D-CEFF-4177-818A-393DF9315A30

Q46923743-89744F22-1B01-443E-BFBA-A76C3A020347

Q46923743-B58E5FB6-E1E3-4252-AFCB-C9B71A6DD8D3

Q46923743-EB8DEF84-8DBE-4575-A2B5-194CA7FF8A20

P2860

Q46923743-02F68F46-F8FB-4357-A534-2DFA3DED8E74

Q46923743-0627E49F-333A-463C-A719-8C1CC77E8F3B

Q46923743-0A139766-D365-47E4-936F-E2C4F5751A93

Q46923743-15604748-E441-431E-8482-9C2DC74FBC51

Q46923743-1D639931-71F1-4354-B800-A658CCA5DF1B

Q46923743-1E524C8B-717A-4100-BF2F-6E2E62062D26

Q46923743-1FDC6E59-7A18-46FB-80F2-8B2C44660C53

Q46923743-278C5601-D326-458B-B8E7-F91E464FCD1B

Q46923743-28BE16EB-A2B8-4D71-977D-B84DF2B02EF1

Q46923743-38E0C5DD-9F40-452A-9CE4-B51C208F5C1F

P2888

Q46923743-3606CB80-960F-4FE1-94AC-4CA5248BA167

P304

Q46923743-7187235A-3C7E-44A5-A363-06126A9672BD

P31

Q46923743-821552DD-410F-4684-9EBE-F7BD647D1BBF

P356

Q46923743-49B025B5-F42A-48F5-8238-B7C1CC95A343

P407

Q46923743-DBADF6A8-8E1C-4E50-AFD8-9DC0E1D2C02F

P433

Q46923743-F2CD64D4-8E48-469B-B40F-F4279E94B52E

P478

Q46923743-30D265C1-9D96-4C22-80E1-6DAFCBD3D345

P577

Q46923743-126652D4-BC86-4C5F-BB61-647396D2DD6B

P698

Q46923743-7F291655-FD25-4BB5-95FA-93EE858931FB

P921

Q46923743-53542345-3509-486f-86e6-6f0a07266cec

P356

P1433

Neuropsychopharmacology

P1476

Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines.

@en

P2093

George Hatzidimitriou

http://www.w3.org/2001/XMLSchema#string

George Ricaurte

http://www.w3.org/2001/XMLSchema#string

Jie Yuan

http://www.w3.org/2001/XMLSchema#string

Liqiong Tong

http://www.w3.org/2001/XMLSchema#string

Michael W McLane

http://www.w3.org/2001/XMLSchema#string

Tao Xie

http://www.w3.org/2001/XMLSchema#string

Una McCann

http://www.w3.org/2001/XMLSchema#string

P2860

Immunohistochemical localization and quantification of glial fibrillary acidic protein and synaptosomal-associated protein (mol. wt 25000) in the ageing hippocampus following administration of 5,7-dihydroxytryptamine

Regulating the conducting states of a mammalian serotonin transporter

Alpha-lipoic acid prevents 3,4-methylenedioxy-methamphetamine (MDMA)-induced neurotoxicity.

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

Amphetamine neurotoxicity: accomplishments and remaining challenges.

Effects of p-chloroamphetamine on brain serotonin neurons.

Serotonin neurotoxins--past and present.

The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release.

Neurotoxicity of MDMA and related compounds: anatomic studies.

Cloning and expression of a functional serotonin transporter from rat brain.

P2888

P304

2639-2651

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.NPP.1301031

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16452989

http://www.w3.org/2001/XMLSchema#string

P921